# Kura Oncology, Inc.: Form 8-K, filed Jan 12, 2026

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2026-01-12
- Accepted by EDGAR: Jan 12, 2026, 06:05 ET
- Period: 2026-01-11
- Accession: 0001193125-26-009649
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312526009649/d55582d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312526009649/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312526009649/d55582d8k.htm

Filed Jan 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-009649. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.